| Vista Medical Technologies, Inc. | |||
| Ticker: | VMTI | 5451 Avenida Encinas, Suite A | |
| Exchange: | NASDAQ-National Market | Carlsbad, CA 92008 | |
| Industry: | Manufacturing (SIC Code 3845) | (619) 603-9120 | |
| Type of Shares: | Common Shares | Filing Date: | 3/7/97 | |
| U.S. Shares: | 4,000,000 | Offer Date: | 7/2/97 | |
| Non-U.S. Shares: | 0 | Filing Range: | $8.00 - $10.00 | |
| Primary Shares: | 4,000,000 | Offer Price: | $9.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.63 | |
| Offering Amount: | $36,000,000 | Selling: | $0.35 | |
| Expenses: | - | Reallowance: | $0.10 | |
| Shares Out After: | 12,718,903 |
| Manager | Tier | Phone |
| Goldman, Sachs & Co. | Lead Manager | (212) 902-5959 |
| Salomon Brothers Inc. | Co-manager | (212) 783-2947 |
| Issuer's Law Firm: | Brobeck, Phleger & Harrison |
| Bank's Law Firm: | McDermott, Will & Emery |
| Auditor: | Ernst & Young |
| Registrar/Transfer Agent: | Boston Equiserve Limited Partnership |
Dollar amounts in U.S. millions except for per share data | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/96 | 12/31/96 | ||||
| Revenue: | $2.24 | Assets: | $14.32 | ||
| Net Income: | -$7.44 | Curr Assets: | |||
| EPS: | -$0.86 | Liabilities: | $1.36 | ||
| Prior EPS: | Curr Liabilities: | ||||
| Cash Flow/Oper: | -$6.94 | Equity: | $12.96 | ||
| Cash Flow/Fin: | Cash: | ||||
| Cash Flow/Inv: | |||||
| Business Description |
| The company develops, manufactures and intends to market proprietary visualization and information systems that enable minimally invasive surgical solutions in cardiothoracic, head, neck and spine and other selected microsurgical procedures. The company currently markets three-chip cameras for endoscopy and related surgical instruments and accessories. Vista Medical's visualization and information systems bring together head-mounted display technology originally developed for applications in military aerospace by Kaiser Aerospace and Electronics Corporation and three-dimensional imaging capability from its acquisition of Oktas, Inc. The development and subsequent widespread adoption of minimally invasive surgical approaches have revolutionized many surgical fields, including general surgery, orthopedics, gynecology and urology. Minimally invasive surgical procedures are performed through strategically placed ports or mini-incisions in a patient's body, thereby avoiding the larger incisions used in traditional open surgery. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to fund product introductions, sales and marketing activities, research and development, acquisition of capital equipment for manufacturing scale-up and for working capital and other general corporate purposes. |